Exploring serum metabolic markers for the discrimination of ccRCC from renal angiomyolipoma by metabolomics.
Conclusion: The alterations of serum purine metabolites may be used as potential metabolic markers for the differential diagnosis of ccRCC and RAML.
PMID: 32613842 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research